CARBOCAINE 3% 30 MG
MEPIVACAINE HYDROCHLORIDE : 30 MG · DIN 02271796 · CARESTREAM HEALTH CANADA COMPANY
Health Canada status: CANCELLED POST MARKET
What is CARBOCAINE 3%?
CARBOCAINE 3% 30 MG contains MEPIVACAINE HYDROCHLORIDE : 30 MG. It is listed in the Health Canada Drug Product Database under DIN 02271796, held by CARESTREAM HEALTH CANADA COMPANY, supplied as SOLUTION for BLOCK/INFILTRATION administration. Health Canada currently lists it as cancelled post market, status dated 06-Sep-2018. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02271796 |
|---|---|
| Brand name | CARBOCAINE 3% |
| Generic / active ingredient | MEPIVACAINE HYDROCHLORIDE : 30 MG |
| Manufacturer | CARESTREAM HEALTH CANADA COMPANY |
| Strength | 30 MG |
| Dosage form | SOLUTION |
| Route of administration | BLOCK/INFILTRATION |
| Schedule | Ethical |
| ATC code | N01BB03 MEPIVACAINE |
| AHFS class | 72:00.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 06-Sep-2018 |
| Original market date | 2005-11-21 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code N01BB03 MEPIVACAINE. 7 of 15 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| 3% POLOCAINE DENTAL | 30 MG | LIQUID | DENTSPLY CANADA LIMITED | MARKETED | DIN 02330733 |
| CARBOCAINE 1% | 10 MG | SOLUTION | PFIZER CANADA ULC | MARKETED | DIN 02241999 |
| CARBOCAINE 1% | 10 MG | SOLUTION | PFIZER CANADA ULC | MARKETED | DIN 02242000 |
| CARBOCAINE 2% | 20 MG | SOLUTION | PFIZER CANADA ULC | MARKETED | DIN 02242001 |
| CARBOCAINE 3% | 30 MG | SOLUTION | SEPTODONT | MARKETED | DIN 02474174 |
| ISOCAINE HCL INJ 3% | 30 MG | SOLUTION | NOVOCOL PHARMACEUTICAL OF CANADA INC | MARKETED | DIN 00364304 |
| SCANDONEST 3% PLAIN INJ | 30 MG | SOLUTION | SEPTODONT | MARKETED | DIN 00479934 |
| CARBOCAINE 3% | 30 MG | SOLUTION | KODAK CANADA INC. | CANCELLED POST MARKET | DIN 01985078 |
| CARBOCAINE INJ LIQ 10MG/ML | 10 MG | LIQUID | STERLING WINTHROP INC. | CANCELLED POST MARKET | DIN 01959891 |
| CARBOCAINE INJ LIQ 20MG/ML | 20 MG | LIQUID | STERLING WINTHROP INC. | CANCELLED POST MARKET | DIN 01959913 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.